{"prompt": "['Apremilast', 'Protocol CC-10004-PSOR-020', 'Amgen Inc.', 'Appendix L: Patient Benefit Questionnaire (PBQ)', 'At the start of the treatment, you indicated in a questionnaire how important various goals were', 'in the treatment of your skin disease.', 'Please mark each of the following statements according to the extent that these treatment goals', 'were achieved, thereby indicating if the treatment has benefitted you. If a statement did not', 'apply to you, e.g. because you had no pain, please mark \"did not apply to me\".', 'The current treatment has helped me to', '1', 'be free of pain', 'O', 'o', 'o', 'o', 'o', 'o', '2', 'be free of itching', 'O', 'O', 'O', 'O', 'O', 'O', '3', 'no longer have burning sensations on my skin', 'O', 'O', 'O', 'O', 'O', 'O', '4', 'be healed of all skin defects', 'o', 'o', 'o', 'o', 'O', 'o', '5', 'be able to sleep better', 'O', 'O', 'O', 'O', 'O', 'O', '6', 'feel less depressed', 'O', 'O', 'O', 'O', 'O', 'O', '7', 'experience a greater enjoyment of life', 'o', 'o', 'o', 'O', 'O', 'O', '8', 'have no fear that the disease will become worse', 'O', 'O', 'O', 'O', 'O', 'O', '9', 'be able to lead a normal everyday life', 'O', 'O', 'O', 'O', 'O', 'O', '10', 'be more productive in everyday life', 'o', 'O', 'O', 'o', 'o', 'o', '11', 'be less of a burden to relatives and friends', 'O', 'O', 'O', 'O', 'O', 'O', '12', 'be able to engage in normal leisure activities', 'O', 'O', 'O', 'O', 'O', 'O', '13', 'be able to lead a normal working life', 'O', 'O', 'o', 'o', 'o', 'o', '14', 'be able to have more contact with other people', 'O', 'O', 'O', 'O', 'O', 'O', '15', 'be comfortable showing myself more in public', 'O', 'O', 'O', 'O', 'O', 'O', '16', 'be less burdened in my partnership', 'o', 'O', 'o', 'o', 'o', 'o', '17', 'be able to have a normal sex life', 'O', 'O', 'o', 'O', 'O', 'O', '18', 'be less dependent on doctor and clinic visits', 'O', 'O', 'O', 'O', 'O', 'O', '19', 'need less time for daily treatment', 'o', 'O', 'o', 'o', 'o', 'o', '20', 'have fewer out-of-pocket treatment expenses', 'O', 'O', 'O', 'O', 'O', 'o', '21', 'have fewer side effects', 'O', 'O', 'O', 'O', 'O', 'O', '22', 'find a clear diagnosis and therapy', 'o', 'O', 'o', 'O', 'O', 'o', '23', 'have confidence in the therapy', 'O', 'O', 'O', 'O', 'O', 'O', '24', 'get better skin quickly', 'O', 'O', 'O', 'O', 'O', 'O', '25', 'regain control of the disease', 'o', 'o', 'o', 'o', 'o', 'o', 'Confidential and Proprietary', '86', 'CC-10004-PSOR-020 Amendment 3 FINAL: 01 May 2020', 'EDMS Doc. Number: 24684941 - 22835610']['Apremilast', 'Protocol CC-10004-PSOR-020', 'Amgen Inc.', 'Appendix M: European Quality of Life 5-Dimension Questionnaire (EQ-5D)', 'EQ-5D', 'Health Questionnaire', '(English version for the US)', '\u00a9 1998 EuroQol Group. EQ-5DTM is a trade mark of the EuroQol Group', 'Confidential and Proprietary', '87', 'CC-10004-PSOR-020 Amendment 3 FINAL: 01 May 2020', 'EDMS Doc. Number: 24684941 - 22835610']\n\n###\n\n", "completion": "END"}